Regeneron Pharmaceuticals, Inc.
ISIN US75886F1075
|WKN 881535
Market cap (in EUR)
50,567.54 m
Country
United States
Sector
Healthcare
Dividend yield
0.17%
Overview
Quote
Trade with your broker
Description
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: Dupixent, Evkeeza, Eylea, Inmazeb, and Kevzara. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically humanized mice to produce optimized fully human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, George Damis Yancopoulos, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals United States
Financials
Key metrics
| Market capitalisation, EUR | 50,567.54 m |
| EPS, EUR | 36.59 |
| P/B ratio | 1.94 |
| P/E ratio | 13.43 |
| Dividend yield | 0.17% |
Winst- en verliesrekening (2024)
| Revenue, EUR | 13,129.39 m |
| Net income, EUR | 4,079.34 m |
| Profit margin | 31.07% |
In welke ETF zit Regeneron Pharmaceuticals, Inc.?
Er zijn 374 ETF's die Regeneron Pharmaceuticals, Inc. bevatten. Al deze ETF's staan in de tabel hieronder. De ETF met de grootste weging van Regeneron Pharmaceuticals, Inc. is de VanEck Genomics and Healthcare Innovators UCITS ETF A.
Savings plan offers
Hier vind je informatie over de beschikbaarheid van het beleggingsplan voor dit aandeel. Je kunt de tabel gebruiken om beleggingsplanaanbiedingen voor de geselecteerde investeringsbedrag te vergelijken.
Select your savings amount:
| Broker | Rating | Execution fee | Account fee | |
|---|---|---|---|---|
 | 0,00€ | 0,00€ | View offer* | |
 | 0,00€ | 0,00€ | View offer* |
Source: justETF Research; As of 5/2025; *Affiliate link
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
— The offers are sorted in the following way: 1. Rating 2. Execution fee 3. Number of stock savings plans. The number of stock savings plans is rounded.
— No guarantee can be given for the completeness and correctness of the information listed. The information provided by the online brokers is decisive. In addition to the indicated broker fees, additional costs (e.g. spreads, gratuities and product costs) may apply.
Performance
Returns overview
| YTD | -23.06% |
| 1 month | +6.45% |
| 3 months | -18.80% |
| 6 months | -32.79% |
| 1 year | -42.51% |
| 3 years | -14.57% |
| 5 years | +0.80% |
| Since inception (MAX) | +40.67% |
| 2024 | -15.31% |
| 2023 | +18.11% |
| 2022 | +17.80% |
| 2021 | +45.43% |
Monthly returns in a heat map
Risk
Risk metrics in this section:
- Volatility, annualised, measured for 1, 3 and 5 year periods. The annualised volatility reflects the degree of price fluctuations during a one year period. The higher the volatility, the more significantly the price of the asset (stock, ETF, etc.) has changed in the past. Assets with higher volatility are generally considered more risky. We calculate the volatility based on the data for the past 1, 3 and 5 years so that you can see if price fluctuations for the ETF became stronger or weaker over time.
- Return per risk for 1, 3 and 5 year periods. This is the annualised (i.e. converted to a one year period) past return divided by the past annualised volatility. The metric puts the historical return of an asset in relation to its historical risk and gives you a retrospective indication of the degree of price fluctuation you had to bear with in order to obtain the return. We calculate this parameter for 1, 3 and 5 year periods to display its evolution over time.
- Maximum drawdown for a period. This shows the worst possible loss an investor could have suffered during the respective period, by first buying and subsequently selling the asset at the least favourable prices. For example, if there was the following sequence of daily ETF prices: 10€, 5€, 12€, 20€, an investor would have suffered the worst loss by buying for 10€ and subsequently selling for 5€. Therefore in this case the maximum drawdown would be (5€ - 10€)/10€ = -50%.
Risk overview
| Volatility 1 year | 32.10% |
| Volatility 3 years | 29.74% |
| Volatility 5 years | 29.02% |
| Return per risk 1 year | -1.32 |
| Return per risk 3 years | -0.17 |
| Return per risk 5 years | 0.01 |
| Maximum drawdown 1 year | -56.57% |
| Maximum drawdown 3 years | -56.57% |
| Maximum drawdown 5 years | -56.57% |
| Maximum drawdown since inception | -56.57% |
Rolling 1 year volatility
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
